# Efficacy and Safety of Low-concentration Atropine for Myopia Control in Chinese Children and Adolescents

> **NCT05597163** · NA · UNKNOWN · sponsor: **Shanghai Eye Disease Prevention and Treatment Center** · enrollment: 588 (estimated)

## Conditions studied

- Myopia, Progressive

## Interventions

- **DRUG:** low concentration atropine (0.01%)
- **DRUG:** low concentration atropine (0.025%)
- **DRUG:** low concentration atropine (0.05%)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05597163
- **Lead sponsor:** Shanghai Eye Disease Prevention and Treatment Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-01-15
- **Primary completion:** 2024-11-01
- **Final completion:** 2025-11-01
- **Target enrollment:** 588 (ESTIMATED)
- **Last updated:** 2023-01-11

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05597163

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05597163, "Efficacy and Safety of Low-concentration Atropine for Myopia Control in Chinese Children and Adolescents". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT05597163. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*